Abstract. The proprotein convertase PC5 is encoded by multiple mRNAs, two of which give rise to the COOH-terminal variant isoforms PC5-A (915 amino acids [aa]) and PC5-B (1877 aa). To investigate the differences in biosynthesis and sorting between these two proteins, we generated stably transfected AtT-20 cell lines expressing each enzyme individually and examined their respective processing pattern and subcellular localization. Biosynthetic analyses coupled to immunofluorescence studies demonstrated that the shorter and soluble PC5-A is sorted to regulated secretory granules. In contrast, the COOH-terminally extended and membrane-bound PC5-B is located in the Golgi. The presence of a sorting signal in the COOH-termina138 amino acids unique to PC5-A was demonstrated by the inefficient entry into the regulated secretory pathway of a mutant lacking this segment. EM of pancreatic cells established the presence of immunoreactive PC5 in glucagon-containing granules, demonstrating the sorting of this protein to dense core secretory granules in endocrine cells. Thus, a single PC5 gene generates COOHterminally modified isoforms with different sorting signals directing these proteins to distinct subcellular localization, thereby allowing them to process their appropriate substrates.
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T
HE mammalian subtilisin/kexin-like convertases are proprotein and prohormone proteinases implicated in the processing of numerous precursors. Seven members of this family of enzymes have so far been identified in mammals (for reviews see Seidah et al., 1994 Seidah et al., , 1996 Van de Ven et al., 1993) . These proteins share a conserved catalytic domain, containing the typical Asp/His/Ser triad of subtilisin-like serine proteinases. They also exhibit the presence of a prosegment and a P domain (also called homo B). Apart from these conserved regions, each convertase possesses a distinct COOH-terminal domain exhibiting diverse structural motifs, such as a transmembrane anchor and cytosolic tail, cysteine-rich repeats, or potential amphipathic structures. Furthermore, for three of the mammalian convertases, a differential splicing mechanism leads to the production of COOH-terminally modified isoforms (Seidah et al., 1992; Kiefer et al., 1991; Tsuji et al., 1994; Lusson et al., 1993; Nakagawa et al., 1993a,b; Mbikay et al., 1995) . Multiple molecular forms of the con-vertases are also observed in Aplysia californica (Chun et al., 1994) , Hydra vulgaris (Chan et al., 1992) , Lymnaea stagnalis (Smit et al., 1992) , Caenorhabditis elegans (Thacker et al., 1995) , and Drosophila melanogaster .
While functions have been proposed for the pro, catalytic, and P domains of the convertases, the role of the COOH-terminal segment is less understood. It was postulated that the latter could be involved in cellular sorting, or that it could modulate the enzymatic activity of the adjoined catalytic domain. In this respect, ex vivo coexpression studies demonstrated that the COOH-terminal truncation of furin did not affect the cellular enzymatic activity of this convertase on renin or its mutants (Hatsuzawa et al., 1992) . It was also reported that the three isoforms of Drosophila furinl (dfurinl, dfurinl-CRR, and dfurinl-X) did not display significant differences in either their catalytic activity or cleavage specificity (De Bie et al., 1995) . Thus, the proposed involvement of the COOH-terminal segment in cellular sorting remains open to investigations.
To test the hypothesis that the COOH-terminal domain influences the cellular transport of some convertases, we compared the cellular traffic of soluble PC5-A and membrane-bound PC5-B (Lusson et al., 1993 ; also called PC6-A
Antibodies
The NH2-and COOH-terminal mouse PC5 polyclonal antibodies were obtained by immunization of rabbits using an octopus branched synthetic peptide approach already used for the PC1 NH2-terminal antibody (Basak et al., 1995; Benjannet et al., 1993) . The peptides chosen consisted of the sequences Asp-Tyr-Asp-Leu-Ser-His-Ala-Gln-Ser-Thr-Tyr-Phe-Asn-AspPro-Lys, representing residues 116-132 consisting of the PC5 NH2-terminal sequence after the potential activation site Arg-Thr-Lys-Arg, and Pro-Pro-Gly-His-Tyr-His-Ala-Asp-Lys-Lys-Arg-Cys-Arg-Lys, representing residues 677-690 of mouse PCS.
Other antibodies used were as follows: anti-TGN38 raised in guinea pig (Schiifer et al., 1995) , guinea pig anti-ACTH (Peninsula Laboratories, Inc., Belmont, CA), rabbit anti-cathepsin B (Lee et al., 1995) , rabbit anti-PC2 (Basak et al., 1995; Benjannet et al., 1993) , and rabbit anti-glucagon (Incstar Co., Stillwater, MN).
Biosynthetic Labeling, Immunoprecipitations, and SDS-PAGE Analyses
Biosynthetic analyses were performed as previously described (Benjannet et al., 1993) . Briefly, cells that had reached 80% confluence were washed with PBS, and then switched for 1 h to a methionine-or sulfate-free medium (RPMI 1640) (GIBCO BRL) supplemented with 0.5% FCS. Subsequently, cells were either labeled with [35S]methionine (100 ixCi/ml) or [35S]Na2SO4 (sodium sulfate) (200 ixCi/ml) (Mandel Scientific Co., Ontario, Canada). In temperature-blocking experiments, cells were preincubated in absence of methionine at 37°C, and then labeled with [35S]methionine for 2 h at either 37°C or 20°C. In experiments performed with brefeldin A (Cedarlane Laboratories, Ltd., Ontario, Canada), the drug was used throughout the preincubation and labeling period at a final concentration of 5 Ixg/ml, as described before (Benjannet et al., 1993) . Stimulation of secretion was performed by adding 8Br-cAMP (Sigma Chemical Co., St. Louis, MO) at a final concentration of 5 mM to the incubation medium. At the end of the incubation period, the media were removed and cells were disrupted in lysis buffer (10 mM Tris-HC1, pH 7.5, 150 mM NaC1, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 1 mM EDTA, and 20 p,g/ml PMSF) by incubation on ice for 20 min. The media and cell lysates were precleared in two steps using normal rabbit serum and protein A-agarose, and then immunoprecipitated. All immunoprecipitations were performed as described before (Benjannet et al., 1993) . Endoglycosidase H (Oxford Glycosystems, Ltd., Rosedale, NY) digestions were performed according to the manufacturer's instructions. The immunoprecipitation products were resolved by electrophoresis on 8% polyacrylamide gels (SDS-PAGE) followed by treatment with Entensify (Dupont-New England Nuclear, Wilmington, DE) and autoradiography. For preparative purposes, immunoprecipitated proteins were resolved on 6% SDS-PAGE gels, which were sliced (1 ram). The eluted radiolabeled proteins were subjected to microsequence analysis on a sequenator (model 470A; Applied Biosystems, Foster City, CA) as described (Benjannet et al., 1993) .
Quantification of Bands in Autoradiograms
Gels were exposed to XAR-5 film (Eastman Kodak Co., Rochester, NY) at -800C for multiple time periods. Films were then read by flatbed scanning and analyzed with the Macintosh NIH Image 1.55f program (Apple Computer Inc., Cupertino, CA) by measuring the intensity of each band above background. This measurement permitted the calculation of the amount of labeled proteins secreted in the presence or absence of 8Br-cAMP and to establish the release kinetics of PC5.
Immunofluorescence
Localization of PC5 proteins in transfected ceils was determined by indirect immunofluorescence. Typically, cells were grown on polylysine-coated (Sigma Chemical Co.) chamber slides (Nunc, Inc., Roskilde, Denmark) for 72 h, rinsed once in PBS, and fixed in 4% formaldehyde/0.1% picric acid in 0.1 M phosphate buffer, pH 7.2, for 1 h at 15°C. Cells were then washed several times over 48 h with PBS containing 0.01% Triton X-100 at 4°C and subsequently reacted overnight with the primary antibody diluted in 10% normal goat serum. The PC5 COOH-terminal antiserum was used at a dilution of 1:250. Guinea pig anti-TGN38 antibody was used at a 1:50 dilution, and the guinea pig anti-ACTH was used at 1:75, while the rabbit anti-cathepsin B antibody was diluted at 1:2,000. After rinsing with PBS, cells were incubated for 30 min at 37~C with TRITC-conjugated goat anti-rabbit IgG diluted 1:15 in 10% normal goat serum (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). When primary antibodies were from guinea pig species, the immunoreaction was revealed using a FITC-labeled secondary antibody raised in goat (Jackson ImmunoResearch Laboratories, Inc.) diluted 1:10 in 10% normal goat serum. The combination of antibodies raised in rabbit with those raised in guinea pig led to a double green and red labeling that permitted us to perform colocalization studies. Displacement of PC5 immunoreaction was performed by blocking antibodies with an excess (>5 x 10 -6 M) of the multiple antigenic peptides used for immunization, which was done by preincubation overnight at 4°C with 100 ixl of the 1:100 diluted antibody. Samples were examined using a microscope with standard epifluorescence attachment (Carl Zeiss, Inc., Thornwood, NY), equipped with a Plan-Neofluor x40/ 0.75 objective.
Electron Microscopy
Pancreatic tissue from five normal Sprague-Dawley rats was fixed by immersion in 1% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, for 2 h at room temperature, dehydrated in graded methanol, and embedded in either Lowicryl K4M at -20°C, as previously described (Bendayan, 1984) , or in Unicryl (British Biocell Int., Cardiff, UK) at -20°(; (Scala et al., 1992; Malide et al., 1995) . Thin-sections were cut, mounted on nickel grids with or without Parlodion-coating, and processed for postembedding colloidal gold immunocytochemistry. For immunolabeling, tissue sections were first transferred for 30 min on a drop of 0.15 M PBS, pH 7.2, containing 0.1% ovalbumin, and then incubated overnight at 4°C with the following anti-bodies at a dilution of 1:100: rabbit anti-PC2, rabbit anti-PCS, and rabbit anti-glueagon (Incstar Co.). Sections were then rinsed with PBS and incubated for 30 min at room temperature with the protein A-gold complex prepared with 10 rim gold particles (OD520 = 0.5), as previously described (Bendayan, 1989; Park and Bendayan, 1992) . The grids were then washed with PBS and distilled water, dried, and stained with uranyl acetate before examination. For double immunogold labeling, both sides of the tissue sections were used, according to Bendayan (1982) . Combinations of anti-PC2/anti-PC5, anti-PC2/anti-ghcagon, and anti-PC5/anti-glueagon antibodies were performed on different faces of the grids in conjunction with protein A--gold complexes formed with 5, 10, or 15 nm gold particles. Several control experiments were carried out to assess the specificity of the labeling obtained. For these controls, incubation was performed with normal serum or specific antibodies preadsorbed overnight with an excess of their corresponding antigens.
Results

Expression of PCS-A and PCS-B in Stably Transfected AtT-20 Cells
To test the hypothesis that the PC5 isoforms ( Fig. 1) could be sorted to different compartments of the secretory pathway, stable transfectants of PC5-A or PC5-B were established in the mouse corticotroph AtT-20 cell line. This cell line was chosen since it has been extensively studied in multiple investigations on the sorting of proteins within the constitutive and regulated pathways (Burgess and Kelly, 1987; Matsuuchi and Kelly, 1991) .
The PC5 forms in transfected AtT-20 cells were initially examined by labeling for 2 h with [aSS]sulfate followed by immunoprecipitation. As shown in Fig. 2 , PC5-A-expressing cells produce a major immunoreactive 117-kD protein detected in cell extracts and medium. Immunoprecipitates of the PC5-B-expressing cells revealed the presence in the cell lysate of two PC5-B-specific proteins migrating with an apparent Mr of 210 and 170 kD, the latter form also being detected in the medium (Fig. 2) . A similar result was obtained after a 4-h pulse in which the 210-kD form of PC5-B was more evident in the cell extracts and was not detected in the medium (data not shown). These data suggest that the sulfated 210-kD form that reached the TGN (Hart, 1992; Baeuerle and Huttner, 1987) is not secretable, indicating that it represents membrane-bound PC5-B. The presence of a shed 170-kD immunoreactive form of PC5-B is reminiscent of the fate of another type I membranebound convertase, furin (Rehemtulla et al., 1992) , suggesting that COOH-terminal cleavage of the membraneanchored PC5-B occurs along the secretory pathway. The two bands detected in the cell extracts of an Mr of "~95-105 kD are considered nonspecific, as they are also detected in control AtT-20 cells transfected with the RcCMV expression vector alone.
Precursor-Product Analysis of PCS-A
The proprotein convertases are initially synthesized as zymogens and must undergo excision of their prosegment before they can be activated (see Fig. 1 ). To define the organelle in which prosegment cleavage of pro-PC5-A to PC5-A occurs, pulse-chase analysis of the biosynthetic fate of PC5-A in AtT-20 cells labeled with [35S]methionine was undertaken. As shown in Fig. 3 , after a 1-min pulse, two immunoreactive PC5 products migrating with an apparent Mr of 126 and 117 kD are detected intracellularly. Progressively upon chase, both bands diminish in intensity with the appearance of a 65-kD form 60 min later. At the same time, the secretion of a major ll7-kD protein is observed in the medium, as well as that of a relatively minor 65-kD product that becomes more visible after a 120-min chase.
Since an NH2-terminally directed PC5 antibody is used to perform immunoprecipitations, the 65-kD form represents a COOH-terminally shortened fragment of PC5-A. Quantitative scanning of the autoradiogram revealed that in the medium, the ratio of 65 to 117 kD progressively increases from 0.30 to 0.45 during 2-4-h chase periods, respectively (data not shown).
Protein sequencing was then performed to unequivocally establish the identity of the PC5-A protein forms. As shown in Fig. 4 , [3H]Tyr3 and [3H]Tyr2,U protein sequences were deduced for the 126-kD and the ll7-kD forms, respectively. Based on the reported cDNA sequence and the predicted PC5 primary structure (Lusson et al., 1993) , it can be concluded that the 126-kD form is pro-PC5-A, the sequence of which begins after the predicted signal peptidase cleavage site CysArgThrSArgValTyrThrAsnHis. The ll7-kD protein represents PC5-A, which is produced after cleavage of the 82-amino acid prosegment at the sequence ValValLysLysArgThrLysArgs24,AspT~AspLeuSerHisAlaGlnSer~PheAsnAsp-ProLys. Sufficient amounts of the 65-kD form could not be accumulated to obtain an unambiguous sequence. However, since this fragment is immunoreactive to the NH2-terminal antibody that was raised against the above 15-amino acid peptide starting at the -AspTyrAsp ...-sequence, it likely represents a COOH-terminally truncated product of the 117-kD PC5-A form.
To define whether intracellutar zymogen cleavage of the 126-kD pro-PC5-A is an early event, the protein was blocked in anterior secretory pathway compartments using the fungal metabolite brefeldin A (BFA) 1. This agent 1. Abbreviations used in this paper. BFA, brefeldin A; POMC, pro-opiomelanocortin; TMD, transmembrane domain.
[3SS] methlonlne Figure 3 . Endoproteolytic transformations of PC5-A. PC5-Atransfected cells were pulse labeled with [35S]methionine for 1 rain (pl), and then chased (c) for 30, 60, or 120 min, followed by immunoprecipitation with a polyclonal rabbit anti-NH2-terminal PC5 antiserum and resolution on 8% SDS-PAGE gels. A more contrasted exposure is given to show the intracellular production of the 65-kD fragment. Molecular masses are given in kD.
causes the disassembly of the Golgi complex and fusion of the cis-, medial-, and trans-Golgi (but not the TGN) with the ER (Lippincott-Schwartz et al., 1989 . In the presence of BFA, the conversion of the 126-kD pro-PC5-A into the ll7-kD PC5-A is still observed (Fig. 5 a) , but COOH-terminal truncation generating the 65-kD product is no longer detected. Thus, NH2-terminal prosegment processing can occur in early compartments of the secretory pathway, but not COOH-terminal truncation. Furthermore, the absence of sulfation of the 126-kD form (Fig. 2) is taken as evidence that pro-PC5-A does not reach the TGN, where sulfation is known to take place (Hart, 1992; Bauerle and Huttner, 1987) . Endoglycosidase H digestions were also performed and demonstrated that the 126-kD pro-PC5-A was digested by endoglycosidase H during chase times of up to 4 h, while the intracellular and secreted 117-and 65-kD forms were resistant to this treatment after a 1-h chase (data not shown).
Since the COOH-terminal truncation generating the 65-kD product does not occur in the presence of BFA (Fig. 5 a) , this cleavage must occur in a late compartment of the secretory pathway. To further substantiate this hypothesis, an experiment at a restrictive temperature of 20°C, which traps secretory proteins at the level of the TGN (Matlin and Simons, 1983) , was performed. The formation of the 65-kD product was not observed at 20°C (Fig. 5 b) . Therefore, COOH-terminal truncation of PC5-A occurs after egress of the ll7-kD form out of the TGN.
Cellular Processing of PCS-B
As already shown in Fig. 2 , in AtT-20 cells stably transfected with PC5-B, the sulfated protein forms that reach the TGN have an apparent Mr of 210 and 170 kD. Since only the 170-kD form is secreted in the medium, this suggests that the 210-kD sulfated protein is retained intracellularly via the transmembrane domain (TMD). In a similar time course to PC5-A (Fig. 3) , pulse labeling of these cells with [35S]methionine for 1 min followed by chase times of up to 2 h demonstrated that the 170-kD COOH-terminally truncated form is first detected in the cell extracts and medium after a 60-min chase period (Fig. 6 a) . Since the 170-kD product is detected in the cell extracts, COOH-terminal truncation of PC5-B therefore occurs intracellularly. To determine whether the production of the 170-kD form is an early or late event along the secretory pathway, 
PC5-A Enters Secretory Granules While PC5-B Is Localized in the Golgi
Biosynthetic studies. Since both 117-and 65-kD PC5-A (Fig. 3) and the 170-kD PC5-B (Fig. 6 ) are secreted in the medium, it was essential to determine whether each of these forms was released through the same secretory pathway. The basal and stimulated release of PC5-A and PC5-B in several of our clonal cell lines was thus compared by labeling of the cells for 2 h with [35S]sulfate in the presence (+) or absence (-) of 8Br-cAMP. In Fig. 7 a, the release of the ll7-kD PC5-A is seen to increase up to threefold in the presence of the secretagogue. Since the 65-kD PC5-A product is not sulfated, the experiment was Fig. 7 b demonstrate that the release of the 65-kD PC5-A form is also stimulated in presence of 8Br-cAMP. In contrast, the level of the secreted 170-kD PC5-B remains virtually unchanged upon this treatment (Fig. 7 a) . The ratio of stimulated over nonstimulated bands was calculated by scanning and quantification of the autoradiograms, and it was found to be 0.90 for PC5-B and 2.5 for PC5-A (average values, see Table I ). This suggests that while the 117-and 65-kD forms of PC5-A can enter secretory granules, the shed form of PC5-B (170 kD) exits from the cell via the constitutive secretory pathway (Burgess and Kelly, 1987) .
To provide further evidence that the PC5-A sorting signal to secretory granules resides in its COOH-terminal region, a mutant PC5-A construct was produced, in which the last 38 amino acids unique to PC5-A were deleted (see Fig. 1 ). This mutant PC5-A~ exhibits a biosynthetic pattern similar to that of PC5-A in pulse-chase experiments, with the presence of 122-and ll3-kD forms in the cell extracts (Fig. 8) . A notable exception is the production of the 65-kD fragment that, at the 2-h chase period in the me- dium, is reduced by half as compared with wild-type PC5-A (compare Figs. 3 and 8 a) . The release of this PC5-AA mutant was not stimulated by 8Br-cAMP to the same extent as that of the wild-type PC5-A, showing only a 1.2-fold increase, while PC5-A release could be augmented by up to threefold in the presence of this secretagogue (Fig. 8 b and Table I ).
65-,,-> [~$]n'wlhlonlne
To clarify the type of release of each PC5 protein, secretion kinetics experiments were performed (Fig. 9) . PC5-A-, PC5-AA-, and PC5-B-expressing cells were pulsed for (Fig. 9) . While PC5-A demonstrates secretion kinetics representative of a protein released through the reg- ulated pathway (Grimes and Kelly, 1992; Arvan and Castle, 1987; Chavez et al., 1996) , PC5-B and PC5-AA exhibit notably distinct basal secretion patterns.
Immunofluorescence Analysis. To define more precisely the subcellular localization of PC5 proteins, ART-20 transfected cells were analyzed by immunofluorescence microscopy (Marcinkiewicz et al., 1996) . The data in Fig. 10 a show that PC5-A immunoreactivity exhibits a pattern of puncrate staining observed in the cytoplasm and at the tips of cellular extensions, known to contain secretory granules (Matsuuchi et al., 1988) , and immunostaining at paranuclear positions, which correspond to the Golgi apparatus. Weak immunoreaction could also be seen in the presumptive perinuclear ER. By double immunofluorescence, PC5-A is demonstrated to colocalize with ACTH in secretory granules and Golgi apparatus (Fig. 10, a and b) . The PC5-B labeling pattern (Fig. 10 c) is quite different from that observed for either PC5-A or ACTH (Fig. 10, a and  b) . Immunofluorescence staining of PC5-B (Fig. 10 c) overlaps with that of TGN38 (Fig. 10 d) , a TGN-resident protein (Luzio et al., 1990) . A mutant PC5-AA, lacking the PC5-A-specific COOH-terminal segment (PC5-Adelta; (Fig. 10 g) , and by the displacement of the labeling reaction with excess antigen (data not shown). We note that the labeling pattern of cathepsin B (CB; Fig. 10 h), a marker of lysosomal compartments, is distinct from that observed for PC5 in all our transfected cell lines, although in this case colabeling could not be achieved since both antibodies are from rabbit species.
Immunocytochemical Evidence of PC5 Localization in Pancreatic Glucagon-secreting Cells by EM
To demonstrate that the sorting of PC5-A into secretory granules is not fortuitous or the result of overexpression in AtT-20 cells, the cellular localization of PC5 in pancreas was examined by EM. In single-labeling experiments, glucagon immunogold labeling was present over the electrondense structure of secretory granules, in cells displaying the characteristics of the A cells (Park and Bendayan, 1992) (Fig. 11 a) . Using antibodies against the convertases PC2 and PC5 in conjunction with protein A-gold complexes, the gold particles were shown to be associated with the secretory granules of the A cells (Fig. 11, b and c) . Double-labeling experiments revealed the colocalization of both PC2 and PC5 within the same granules of the A cells (Fig. 11 d) . Double labeling using antibodies to PC2 or PC5 together with a glucagon-specific antibody demonstrated that the majority of glucagon-rich granules also display PC2 or PC5 immunoreactivity (Fig. 11 , e and J0.
Discussion
In this work, the biosynthesis and transport of PC5-A and PCS-B, two isoforms generated from a single gene (Mbikay et al., 1995) , were investigated. Specifically, their respec- 
Biosynthetic Fates of PC5-A and PC5-B
Initially, since data were not available on the biosynthesis of PC5, analysis in cells that endogenously express relatively high levels of its mRNA, namely BSC40 cells (Nakagawa et al., 1993a) , was attempted. However, detection of sufficient amounts of [35S]methionine-labeled PC5-A above background was unsuccessful. This approach was thus unsuitable to undertake extensive biosynthetic studies on PC5. Hence, the isolation of stable transfectants overexpressing PC5 was preferred, allowing in addition the comparison of the biosynthetic fate and transport of the isoforms PC5-A and PC5-B.
Pulse-chase analysis performed in transfected cells demonstrated that PC5-A is initially produced as pro-PC5-A, and rapidly processed to PC5-A (within a 1-min pulse) in early compartments of the secretory pathway, in a fashion similar to that of the granule-associated convertase PC1 (Benjannet et al., 1993) . Pro-PC5-A predominates intracellularly, even after chase periods of up to 2 h (Fig. 3) . It is possible that the intracellular predominance of pro-PC5-A over PC5-A at all chase times may be due to its relatively high expression levels in transfectant clones. As assessed by its persistent sensitivity to endoglycosidase H digestion, pro-PC5-A remains in a compartment where transformation and trimming to complex sugar types does not occur (data not shown). With the added observation that pro-PC5-A is not sulfated (Fig. 2) , whereas PC5-A is, this suggests that the zymogen remains in the ER, and only the NH2-terminally processed PG5-A is allowed to exit from this compartment. This is in contrast to PC2, which is processed in the TGN/granules (Benjannet et al., 1993) . PC5-A also undergoes COOH-terminal truncation into a 65-kD product, presumably within immature secretory granules. This is again similar to the fate of PC1 (87 kD), which is COOH-terminally cleaved into a 66-kD form, also within granules (Vindrola and Lindberg, 1992; Benjannet et al., 1993) . Based on its size and the PC5-A sequence (Lusson et al., 1993) , and by homology to the re- cently described COOH-terminal cleavage site of PC1 (Zhou and Lindberg, 1994) , the probable cleavage site generating this 65-kD fragment is at the sequence His646TyrHisAla-AspLysLysArg6535Cys.
Pulse-chase analysis of the isoform PC5-B was then undertaken to compare its biosynthetic fate to that of PC5-A. This protein is present in transfected AtT-20 ceils as a membrane-bound 210-kD form and a shed 170-kD product (Figs. 2 and 6, a and b) . The truncated 170-kD product is detected after a 1-h chase both in the cell extracts and medium (Fig. 6 a) , which suggests that COOH-terminal cleavage takes place in an intracellular compartment. Production of the PC5-B 170-kD truncation product is prevented in the presence of BFA, pointing to a late Golgi compartment as the location where COOH-terminal processing takes place. Similarly, the COOH-terminal truncation of membrane-bound furin was demonstrated to take place in the TGN (Vey et al., 1994) . It should be mentioned that the extent of cleavage of the 210-kD form into the 170-kD PC5-B is somewhat dependent on protein expression levels. For example, in clones where expression levels are high, the ratio of the intracellular 210-kD to 170-kD form is in favor of the latter species, whereas this ratio is reversed in moderately expressing clones. This observation may be relevant to the different tissues that express this isoform. For example, in the ileum in which PC5-B mRNA is abundant, production of the 170-kD form would be expected to be more substantial than in lower expressing tissues, such as lung. The membranebound convertases furin (Molloy et al., 1994; Rehemtulla et al., 1992) , the Drosophila furins (De Bie et al., 1995) , and kexin (Germain et al., 1992 ) also exhibit shedding of their TMD, allowing the secretion of active enzymes. This is not only observed in conditions of overexpression (Rehemtulla et al., 1992) , but also for the endogenous furin of Madin-Darby bovine kidney (MDBK) cells (Vey et al., 1994) . Secretion of truncated PC5-B may therefore be physiologically important for the processing of extracellular substrates. A smaller truncation product of 65 kD, such as the one detected for PC5-A, is never observed for PC5-B, even though the cleavage site is present within the region common to both isoforms. Since it was demonstrated that this PC5-A COOH-terminal truncation segment is produced in immature granules, it can be concluded that PC5-B does not enter this compartment.
Although sequencing of the 170-kD form of PC5-B labeled with [3H]tyrosine was attempted several times, it was not possible to obtain unambiguous sequence data, probably as a result of the difficulty of directly sequencing such a large protein (data not shown). The 170-kD protein could be derived from the 210-kD PC5-B by an NH2-and/ or COOH-terminal truncation. Since the loss of 40 kD is much greater than that expected for the 9 kD prosegment, it is likely that the 170-kD form is generated by COOHterminal truncation of the 210-kD PC5-B. Also, the 170-kD product is not retained intracellularly, as would be expected of a form having lost its transmembrane anchor. However, the secreted 170-kD form is presumed to lack the NH2-terminal prosegment as well, since zymogen forms of either PC1, PC2, or furin are not released from AtT-20 cells (Benjannet et al., 1993) . Also, PC5-B activity obtained from recombinant vaccinia virus-infected cells could be detected in vitro in culture media using the fluorogenic substrate pGlu-Arg-Thr-Lys-Arg-methylcoumarin amide (Jean et al., 1993) , concomitant with the observation of a 170-kD protein (Seidah, N.G., unpublished results).
Differential Intracellular Sorting of PCS-A and PCS-B
When expressed in AtT-20 ceils, the two PC5 isoforms were sorted to distinct compartments of the secretory pathway. While the short and soluble PC5-A isoform entered the secretory granules, the membrane-bound PC5-B remained in the Golgi. Immunofluorescence images (Fig.  10 a) agree with the results obtained by biosynthetic labeling (Fig. 7) , both of which demonstrate the presence of PC5-A in secretory granules. PC5-A (Fig. 10 a) , like ACTH (Fig. 10 b) and PC1 (Marcinkiewicz et al., 1996) , exhibits a dual Golgi/granule localization. Since cAMP stimulates the release of both 117-kD and 65-kD forms of PC5-A (Fig. 7 b) , the punctate immunofluorescence found throughout the cytoplasm (Fig. 10 a) is presumed to correspond with granules carrying both products. In contrast, immunofluorescence data demonstrate that PC5-B resides in a compartment where it coloealizes with the TGN marker TGN38 (Luzio et al., 1990) (Fig 10, c and d ).
To further demonstrate that the sorting of PC5-A to secretory granules is neither an artifact nor the result of overexpression in AtT-20 cells, we performed EM studies to demonstrate the presence of PC5 in the granules of an endocrine tissue. The data (Fig. 11) clearly demonstrate that PC5 colocalizes with both glucagon and PC2 within the granules of the pancreatic A cells. The presence of PC5 in the Golgi could not be established, as a result of the scarcity of this organelle in these cells. Further undertakings are needed to demonstrate the presence of PC5 in the Golgi of pancreatic A ceils at the EM level and to determine which form of PC5 prevails in this cellular compartment.
The pancreatic A cells provide a physiological model for the sorting of PC5 in an endocrine tissue. In agreement, in two glucagon-expressing cell lines, the 65-kD PC5-A product has been detected by Western blotting (Blache et al., 1994) . One of these ceil lines, namely aTC1-6, is derived from the pancreatic A cells (Hamaguchi and Leiter, 1990) . This strongly suggests that PC5-A, and not PC5-B, is the species detected in the A cells of the pancreas.
The principal sorting signal that permits PC5-A to enter secretory granules seems to reside within its unique COOH-terminal 38 amino acids. Indeed, a truncation mutant of PC5-A in which this segment was removed was no longer detected in the secretory granules of AtT-20 cells by immunofluorescence microscopy (Fig. 10 e) . Moreover, 8Br-cAMP stimulation of the release of this protein only resulted in a 1.2-fold increase of secretion in the medium, while that of wild-type PC5-A could be augmented by up to three times (Table I) . Therefore, PC5-AA seems to have lost its capacity to efficiently enter secretory granules.
The secretion kinetics of PC5-AA are also quite distinct from those of PC5-A. In Fig. 9 , where the basal releases of PC5-A, PC5-AA, and soluble PC5-B are compared, PC5-A demonstrates a secretion pattern typical of proteins released through the regulated secretory pathway of trans- formed cell lines, while PC5-AA and soluble PC5-B exhibit linear constitutive releases. Tumor-derived oadocrine cell lines have been demonstrated to have a high rate of basal, unstimulated release of granule contents. This is especially true of AtT-20 cells (Matsuuchi and Kelly, 1991; Milgram etal., 1994) , which release about half of their granule content of ACTH in an mastimulated fashion (Moore etal., 1983) . Therefore, Fig. 9 depicts this unstimulated granule exocytosis of PC5-A, which is initially rapid and thought to occur through immature granules, and then reaches a plateau as the protein accumulates in the mature secretory granules.
The basal release of PC5-AA and the soluble form of PC5-B, on the other hand, is believed to occur through constitutive vesicles, as their content increases linearly with time in the extraceUular medium. The observed rate of release of PC5-B is the lowest of the three PC5 forms, probably because this protein must first undergo excision of its transmembrane domain before being released into the extracellular medium. The fact that the initial rate of release of PC5-A is higher than that of the mutant PC5-AA may be due (a) to the fact that the expression levels of PC5-A in the cell lines analyzed are higher than those of PC5-AA, and therefore the PC5-A overflow from granules is more important than the constitutive release of the mutant; or (b) to the release of PC5-AA from the cell being delayed by the slower rate of exit of this protein out of the ER, as the mutation introduced in the COOH-terminal domain could affect the proper folding of this protein.
The small increase of PC5-AA release in the presence of 8Br-cAMP (Fig. 8 b ; Table I ) could be explained by the entry of this protein in immature secretory granules, as these organelles can release their content upon stimulation (T.ooze etal., 1991) . This is further supported by the production of a 65-kD truncation product at 37"C, but not at 200C, by both PC5-A (Fig. 5 b) and PC5-AA (data not shown). In comparison, PC5-B is never processed into this smaller truncation product, even though the cleavage site is pre~ont within the region common to both isoforms. The differential sorting of PC5-A and PC5-AA could therefore oeet~ .in immature granules (Aryan and Castle, 1992; Bauerfeind and Huttner, 1993) , from which PC5-AA could be released through the constitutive-like pathway (Kuliawat and Aryan, 1994) . Alternatively, PC5-AA could enter the immature granules, but then be recycled from this compartment back to the TGN to be released through constitutive vesicles.
Sequence-specific Sorting Signals of PCS-A and PCS-B
PCS.-A. In an attempt to uncover a potential granule-sorting signal, the sequence unique to PC5-A was tentatively aligned with those of other proteins known to enter the secretory granules, namely chromogranin B and pro-opiomelanocortin (POMC). A consensus sequence emerged that ~ conformed to the signals already defined for ehromogranin B (Chanat etal., 1993) and POMC (Cool et al., 1995) . This consensus sequence consists of two cysteines, which in the cases of chromogranin B and POMC (Bennett etal., 1986) have been demonstrated to form a disulfide bond, and conserved hydrophobic residues, especially a central leucine (Fig. 12 a) . This motif is also observed in chromogranin A (Benedurn etal., 1987) and in the convertase PACE4-A (Kiefer etal., 1991) . We may therefore have identified a potential granule-sorting signal for PC5-A, which could also be functional in the convertase PACE4-A. Further studies are needed to demonstrate whether this signal is a true sorting domain and can act on constitutively secreted proteins, as was accomplished with chimeras of the prosegment of anglerfish so-. matostatin-1 and ct-globin (Stoller and Shields, 1989) . We conclude that the COOH-terminal 38-amino acid sequence is involved in the sorting of PC5-A to the regulated pathway. This segment may be necessary for the presumed calcium-induced aggregation of PC5-A, allowing its entry into mature secretory granules (Burgess and Kelly, 1987; Tooze etal., 1993) . This does not exclude thepossibility that additional sorting signals are present in other PC5 domains. Studies with both POMC (Chevrier etal., 1993) and somatostatin (Sevarino and Stork, 1991) demonstrated that multiple sorting signals to the regulated secretory pathway exist in these molecules.
PC5-B.
Potential signals permitting the retention of PC5-B in Golgi compartments were likewise investigated, by comparing its COOH-terminal-specific .sequence to those of other membrane-bound proprotein processing enzymes.
Several trafficking signals governing TGN localization have been recently defined to reside within the cytoplasmic tail of the convertase furin (Molloy et al., 1994; Chapman and Munro, 1994; Voorhees et al., 1995; Schafer et al., 1995; Jones et al., 1995; Takahashi et aL, 1995~ Bosshart et al., 1995 . These include (a) a cluster of acidic amino acids in the sequence CPSDSEEDEG, where the phosphorylation of both serines by a caseine kinase H-like enzyme plays an important modulatory role in the retrieval of fufin to the TGN (Jones et al., 1995; Takahashi et al., 1995) ; (b) a Tyr-containing motif, where the tetrapeptide consensus sequence Y-XX-(hydrophobic) is a necessary and sufficient cytoplasmic domain signal to retrieve integral membrane proteins from the cell surface to the TGN (Trowbridge et al., 1993) ; and (c) adjacent leucine and/or isoleucine residues, termed dileucine signal, which,-has been described as an internalization motif (Johnson and Kornfeld, 1992) .
All three signals are present in the cytosolic tail of PC5-B (Fig. 12 b) . Two acidic clusters are seen in mouse PC5-B, within the sequence (Nakagawa et al., 1993b) : TMD-28aa-S_YLDEDQVIEYRDRDYDEDDEDD-19aa-DETEDDE-LEYDDE-5aa-COOH, with two potential (Ser and Thr) casein kinase II phosphorylation sites. Both acidic dusters and the casein kinase II phosphorylation site at the serine residue are conserved in rat PC5-B (GenBank accession number: Pcsk5 V47014). The cytosolic sequence of PC5-B also exhibits four Tyr-containing motifs: TMD-12aa-YEKL6aa-YSSY-35aa-YRKF-laa-YGLL-18aa-COOH, which could be potentially functional. Interestingly, PC5-B (LeuLeu, at two positions), furin (Leulle), and PC7 (LeuLeu, at two positions) all contain a dileucine motif within their cytoplasmic tail. Future internalization studies aimed specifically at detecting PC5-B at the cell surface and its predicted retrieval to intracellular compartments should assess the implication of the Tyr-containing and/or dileucine signals in this process. Alignment of the known cytoso!ic tail localization motives of furin, PC7, kexin (Wilcox et al., 1992) , and TGN38 (Humphrey et al., 1993; Bos et al., 1993; Wong and Hong, 1993; Ponnambalam et al., 1994; Wilde et al., 1994) , all membrane-bound protein residents of the Golgi or TGN, with the motives seen in PC5-B, is shown in Fig. 12b .
In conclusion, PC5-A and PC5-B constitute the first example for the convertase family of processing enzymes, in which two active forms originating from a single gene exhibit distinct cellular localization. This may represent a mechanism to regulate bioactive enzymes by directing them to different subcellular destinations to process unique sets of precursor substrates. Since the convertases exhibit overlapping tissue distrib~ations as well as in vitro or ex vivo cleavage specificiti~s, the formation of the appropriate convertase/substrate combinations could ultimately be regulated by their particular intracellular localization.
